Condition
Adverse Effect of Radiation Therapy
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownEffects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer PatientsNCT02922244 · 2016-05-01
COMPLETEDStudy to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the HeartNCT02052102 · 2014-10-01
UNKNOWNIORT-Boost-Study, Prospective Observational Study for Intraoperative Radiotherapy of the Breast as a BoostNCT02114086 · 2013-01-01
UNKNOWNEvaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma BreastNCT02142907 · 2013-01-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
UNKNOWN2
Phase mix
NA1
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.